National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

Spinocerebellar ataxia 1



Other Names:
SCA1; Spinocerebellar ataxia type 1; Olivopontocerebellar atrophy 1; SCA1; Spinocerebellar ataxia type 1; Olivopontocerebellar atrophy 1; OPCA1; Cerebelloparenchymal disorder 1; Menzel type OPCA; Olivopontocerebellar atrophy 4; OPCA4; Schut-Haymaker type OPCA; Spinocerebellar atrophy 1 See More
Categories:
This disease is grouped under:

Spinocerebellar ataxia type 1 (SCA1) is a progressive movement disorder that typically begins in early adulthood (but can affect children and older adults as well). Early signs and symptoms includes problems with coordination and balance (ataxia), speech and swallowing difficulties, muscle stiffness, and weakness in the muscles that control eye movement. Over time, SCA1 may cause mental impairment, numbness, tingling, or pain in the arms and legs and uncontrolled muscle tensing, wasting, and twitches. SCA1 is caused by changes in the ATXN1 gene and is inherited in an autosomal dominant fashion. There is currently not a cure for SCA1, but treatments are available to help manage symptoms. People with SCA1 typically survive 10 to 30 years after symptoms first appear.[1][2]
Last updated: 2/24/2016

This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.

Showing of 65 |
Medical Terms Other Names
Learn More:
HPO ID
80%-99% of people have these symptoms
Progressive cerebellar ataxia 0002073
30%-79% of people have these symptoms
Abnormal flash visual evoked potentials 0007928
Abnormal nerve conduction velocity 0040129
Abnormality of somatosensory evoked potentials 0007377
Atrophy/Degeneration affecting the brainstem 0007366
Bradykinesia
Slow movements
Slowness of movements
[ more ]
0002067
Bulbar signs 0002483
Cerebellar atrophy
Degeneration of cerebellum
0001272
Chorea 0002072
Dysarthria
Difficulty articulating speech
0001260
Dysphagia
Poor swallowing
Swallowing difficulties
Swallowing difficulty
[ more ]
0002015
Dystonia 0001332
Inertia 0030216
Loss of Purkinje cells in the cerebellar vermis 0007001
Memory impairment
Forgetfulness
Memory loss
Memory problems
Poor memory
[ more ]
0002354
Slow saccadic eye movements
Slow eye movements
0000514
Slurred speech 0001350
Staring gaze 0025401
Upgaze palsy 0025331
5%-29% of people have these symptoms
Abnormality of masticatory muscle 0410011
Dysdiadochokinesis
Difficulty performing quick and alternating movements
0002075
Dysmetria
Lack of coordination of movement
0001310
Fasciculations
Muscle twitch
0002380
Gait imbalance
Abnormality of balance
Abnormality of equilibrium
Imbalanced walk
[ more ]
0002141
Generalized hypotonia
Decreased muscle tone
Low muscle tone
[ more ]
0001290
Hyperactive deep tendon reflexes 0006801
Hypermetric saccades 0007338
Hyporeflexia
Decreased reflex response
Decreased reflexes
[ more ]
0001265
Impaired proprioception 0010831
Nystagmus
Involuntary, rapid, rhythmic eye movements
0000639
Ophthalmoparesis
Weakness of muscles controlling eye movement
0000597
Optic atrophy 0000648
Postural tremor 0002174
Respiratory failure 0002878
Skeletal muscle atrophy
Muscle degeneration
Muscle wasting
[ more ]
0003202
1%-4% of people have these symptoms
Decreased amplitude of sensory action potentials 0007078
Decreased motor nerve conduction velocity 0003431
Decreased sensory nerve conduction velocity 0003448
Percent of people who have these symptoms is not available through HPO
Abnormality of extrapyramidal motor function 0002071
Adult onset
Symptoms begin in adulthood
0003581
Areflexia
Absent tendon reflexes
0001284
Autosomal dominant inheritance 0000006
Babinski sign 0003487
Bulbar palsy 0001283
Cognitive impairment
Abnormality of cognition
Cognitive abnormality
Cognitive defects
Cognitive deficits
Intellectual impairment
Mental impairment
[ more ]
0100543
Dilated fourth ventricle 0002198
Distal amyotrophy
Distal muscle wasting
0003693
Dorsal column degeneration 0007006
Dysmetric saccades
Uncoordinated eye movement
0000641
Gaze-evoked nystagmus 0000640
Genetic anticipation with paternal anticipation bias 0003744
Hyperreflexia
Increased reflexes
0001347
Impaired horizontal smooth pursuit 0001151
Impaired vibratory sensation
Decreased vibration sense
Decreased vibratory sense
Diminished vibratory sense
Impaired vibratory sense
[ more ]
0002495
Limb ataxia 0002070
Muscular hypotonia
Low or weak muscle tone
0001252
Olivopontocerebellar atrophy 0002542
Optic disc pallor 0000543
Scanning speech
Explosive speech
0002168
Spasticity
Involuntary muscle stiffness, contraction, or spasm
0001257
Spinocerebellar atrophy 0007263
Spinocerebellar tract degeneration 0002503
Supranuclear ophthalmoplegia 0000623
Truncal ataxia
Instability or lack of coordination of central trunk muscles
0002078
Urinary bladder sphincter dysfunction 0002839
Showing of 65 |
Last updated: 7/1/2020

Making a diagnosis for a genetic or rare disease can often be challenging. Healthcare professionals typically look at a person’s medical history, symptoms, physical exam, and laboratory test results in order to make a diagnosis. The following resources provide information relating to diagnosis and testing for this condition. If you have questions about getting a diagnosis, you should contact a healthcare professional.

Testing Resources

  • The Genetic Testing Registry (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.
  • Spinocerebellar Ataxia: Making an Informed Choice about Genetic Testing is a booklet providing information about spinocerebellar ataxia and is available as a PDF document on the University of Washington Medical Center Web site. Click on the title above to view this resource.

If you need medical advice, you can look for doctors or other healthcare professionals who have experience with this disease. You may find these specialists through advocacy organizations, clinical trials, or articles published in medical journals. You may also want to contact a university or tertiary medical center in your area, because these centers tend to see more complex cases and have the latest technology and treatments.

If you can’t find a specialist in your local area, try contacting national or international specialists. They may be able to refer you to someone they know through conferences or research efforts. Some specialists may be willing to consult with you or your local doctors over the phone or by email if you can't travel to them for care.

You can find more tips in our guide, How to Find a Disease Specialist. We also encourage you to explore the rest of this page to find resources that can help you find specialists.

Healthcare Resources


Research helps us better understand diseases and can lead to advances in diagnosis and treatment. This section provides resources to help you learn about medical research and ways to get involved.

Clinical Research Resources

  • ClinicalTrials.gov lists trials that are related to Spinocerebellar ataxia 1. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

    Please note: Studies listed on the ClinicalTrials.gov website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.

Patient Registry

  • Coordination of Rare Diseases at Sanford (CoRDS) hosts a specific registry for patients with ataxia in partnership with the National Ataxia Foundation. The goal of the CoRDS registry is to connect as many patients and researchers as possible to help advance treatments and cures for rare diseases. The CoRDS registry is free for patients to enroll and for researchers to access.

Support and advocacy groups can help you connect with other patients and families, and they can provide valuable services. Many develop patient-centered information and are the driving force behind research for better treatments and possible cures. They can direct you to research, resources, and services. Many organizations also have experts who serve as medical advisors or provide lists of doctors/clinics. Visit the group’s website or contact them to learn about the services they offer. Inclusion on this list is not an endorsement by GARD.

Organizations Supporting this Disease


Living with a genetic or rare disease can impact the daily lives of patients and families. These resources can help families navigate various aspects of living with a rare disease.

Financial Resources


These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.

Where to Start

In-Depth Information

  • GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.
  • The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
  • Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine. 
  • Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
  • PubMed is a searchable database of medical literature and lists journal articles that discuss Spinocerebellar ataxia 1. Click on the link to view a sample search on this topic.

Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know. Submit a new question

  • Is it common to have bowel problems when you have SCA1? See answer



  1. Spinocerebellar ataxia type 1. Genetic Home Reference. Reviewed February 2011; http://ghr.nlm.nih.gov/condition/spinocerebellar-ataxia-type-1. Accessed 2/24/2016.
  2. Bird TD. Hereditary Ataxia Overview. GeneReviews. November 26, 2014; http://www.ncbi.nlm.nih.gov/books/NBK1138/. Accessed 2/17/2015.
  3. Frequently asked questions about sporadic ataxia and multiple system atrophy (MSA). National Ataxia Foundation. https://www.ataxia.org/pdf/Sporadic.pdf. Accessed 2/24/2016.
  4. Mähler A et al.,. Increased catabolic state in spinocerebellar ataxia type 1 patients. Cerebellum. 2014 Aug; 13(4):440-6. Accessed 2/24/2016.